Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2595)
All Articles published online
|
Aug 28, 2006 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Azzariti A, Porcelli L, Xu JM, Simone GM, Paradiso A. Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects. World J Gastroenterol 2006; 12(32): 5140-5147 [PMID: 16937523 DOI: 10.3748/wjg.v12.i32.5140] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i32/5140.htm |
| Number | Citing Articles |
| 1 |
Lalit Mohan Negi, Manu Jaggi, Vidushi Joshi, Kar Ronodip, Sushama Talegaonkar. Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer. International Journal of Biological Macromolecules 2015; 73: 222 doi: 10.1016/j.ijbiomac.2014.11.026
|
| 2 |
Gianluigi Giannelli, Concetta Sgarra, Letizia Porcelli, Amalia Azzariti, Salvatore Antonaci, Angelo Paradiso. EGFR and VEGFR as potential target for biological therapies in HCC cells. Cancer Letters 2008; 262(2): 257 doi: 10.1016/j.canlet.2007.12.001
|
| 3 |
Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy, György Várady, Katalin Német, Csilla Özvegy-Laczka, György Kéri, László Őrfi, Gergely Szakács, Jeffrey Settleman, András Váradi, Balázs Sarkadi. Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance. Biochemical Pharmacology 2012; 84(3): 260 doi: 10.1016/j.bcp.2012.04.010
|
| 4 |
Csilla Hegedüs, Tamás Hegedüs, Balázs Sarkadi. Resistance to Targeted ABC Transporters in Cancer. Resistance to Targeted Anti-Cancer Therapeutics 2015; 4: 209 doi: 10.1007/978-3-319-09801-2_9
|
| 5 |
Rahul V. Patel, Bhupendra M. Mistry, Riyaz Syed, Nikhil M. Parekh, Han-Seung Shin. Pyrrolo[1,2-a]azepines Coupled with Benzothiazole and Fluorinated Aryl Thiourea Scaffolds as Promising Antioxidant and Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(15): 1855 doi: 10.2174/1871520619666190820151043
|
| 6 |
|
| 7 |
|
| 8 |
Denisa Lizoňová, Filip Hládek, Stanislav Chvíla, Adam Baláž, Štěpánka Staňková, František Štěpánek. Surface stabilization determines macrophage uptake, cytotoxicity, and bioactivity of curcumin nanocrystals. International Journal of Pharmaceutics 2022; 626: 122133 doi: 10.1016/j.ijpharm.2022.122133
|
| 9 |
Yingying Lu, Jianliang Zhang, Jiaming Qian. The Effect of Emodin on VEGF Receptors in Human Colon Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals 2008; 23(2): 222 doi: 10.1089/cbr.2007.0425
|
| 10 |
Stefan Langhammer, Robert Koban, Constanze Yue, Heinz Ellerbrok. Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa™). Antiviral Research 2011; 89(1): 64 doi: 10.1016/j.antiviral.2010.11.006
|
| 11 |
Janet Morgan, Jennifer D. Jackson, Xiang Zheng, Suresh K. Pandey, Ravindra K. Pandey. Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy. Molecular Pharmaceutics 2010; 7(5): 1789 doi: 10.1021/mp100154j
|
| 12 |
Amalia Azzariti, Letizia Porcelli, Giuliana Gatti, Angelo Nicolin, Angelo Paradiso. Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cells. Biochemical Pharmacology 2008; 75(5): 1035 doi: 10.1016/j.bcp.2007.11.018
|
| 13 |
A Azzariti, G Bocci, L Porcelli, A Fioravanti, P Sini, G M Simone, A E Quatrale, P Chiarappa, A Mangia, S Sebastian, D Del Bufalo, M Del Tacca, A Paradiso. Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. British Journal of Cancer 2011; 104(5): 769 doi: 10.1038/bjc.2011.21
|
| 14 |
Aleksandra Sochacka-Ćwikła, Marcin Mączyński, Żaneta Czyżnikowska, Benita Wiatrak, Izabela Jęśkowiak, Albert Czerski, Andrzej Regiec. New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research. International Journal of Molecular Sciences 2022; 23(19): 11694 doi: 10.3390/ijms231911694
|
| 15 |
Lalit Mohan Negi, Sushama Talegaonkar, Manu Jaggi, Anita Kamra Verma, Ritu Verma, Sheetal Dobhal, Vijay Kumar. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation. Colloids and Surfaces B: Biointerfaces 2014; 123: 600 doi: 10.1016/j.colsurfb.2014.09.062
|
| 16 |
Rahul V. Patel, Bhupendra M. Mistry, Riyaz Syed, Nikhil M. Parekh, Han‐Seung Shin. Sulfonylpiperazines based on a flavone as antioxidant and cytotoxic agents. Archiv der Pharmazie 2019; 352(9) doi: 10.1002/ardp.201900051
|
| 17 |
Amalia Azzariti, Letizia Porcelli, Grazia M. Simone, Anna E. Quatrale, Nicola A. Colabufo, Francesco Berardi, Roberto Perrone, Massimo Zucchetti, Maurizio D’Incalci, Jian Ming Xu, Angelo Paradiso. Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences. Cancer Chemotherapy and Pharmacology 2010; 65(2): 335 doi: 10.1007/s00280-009-1039-0
|